Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 35 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 9662424

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted May 30, 2017 · Expires May 25, 2037

    granted

  2. US 9656001

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted May 23, 2017 · Expires May 18, 2037

    granted

  3. US 9655909

    Personalized medicine for the prediction of therapy targeting the hedgehog pathway

    The Board of Regents of the University of Texas System · Granted May 23, 2017 · Expires May 18, 2037

    granted

  4. US 9649373

    Neoseptins: small molecule adjuvants

    The Board of Regents of the University of Texas System · Granted May 16, 2017 · Expires May 11, 2037

    granted

  5. US 9649344

    Methods and compositions for in vivo induction of pancreatic beta cell formation

    The Board of Regents of the University of Texas System · Granted May 16, 2017 · Expires May 11, 2037

    granted

  6. US 9645139

    Neuroprotective chemicals and methods for identifying and using same

    The Board of Regents of the University of Texas System · Granted May 9, 2017 · Expires May 4, 2037

    granted

  7. US 9642859

    Use of capsazepine and analogs thereof to treat cancer

    The Board of Regents of the University of Texas System · Granted May 9, 2017 · Expires May 4, 2037

    granted

  8. US 9638639

    Plasmonic-magnetic bifunctional nanotubes for biological applications

    The Board of Regents of the University of Texas System · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

  9. US 9630990

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  10. US 9631041

    PH-sensitive compositions for delivery of beta lapachone and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  11. US 9629877

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  12. US 9624484

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  13. US 9622974

    Formation of stable submicron peptide or protein particles by thin film freezing

    The Board of Regents of the University of Texas · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  14. US 9624211

    Anti-cancer compounds

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  15. US 9616048

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  16. US 9618521

    Sperm-specific cation channel, Catsper2, and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  17. US 9616076

    Methods for treating viral infections using hydrogen sulfide donors

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  18. US 9617511

    Tissue-specific differentiation matrices and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  19. US 9611266

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  20. US 9611292

    Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  21. US 9605057

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  22. US 9598694

    Micro-RNAs involved in macular degeneration

    The Board of Regents of the University of Texas System · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  23. US 9592238

    Anti-ceramide monoclonal antibody 2A2

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  24. US 9593131

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.